3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
372
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Leukemia
218
Hematologic Neoplasms
160
Leukemia, Lymphocytic, Chronic, B-Cell
129
Lymphoma
107
Myelodysplastic Syndromes
90
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Lymphoma, Non-Hodgkin
66
Recurrence
63
Lymphoma, Large B-Cell, Diffuse
50
Lymphoma, Follicular
47
Lymphoma, Mantle-Cell
44
Multiple Myeloma
42
Burkitt Lymphoma
41
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
39
Leukemia, B-Cell
39
Neoplasms
38
Leukemia, Myeloid, Chronic-Phase
37
Lymphoma, B-Cell
36
Lymphoma, B-Cell, Marginal Zone
31
Hodgkin Disease
29
Lymphoma, Large-Cell, Immunoblastic
26
Leukemia, Promyelocytic, Acute
23
Leukemia, Myelomonocytic, Chronic
21
Neoplasms, Plasma Cell
19
Myeloproliferative Disorders
19
Congenital Abnormalities
19
Leukemia, Myelomonocytic, Acute
18
Leukemia, Myeloid
18
Interventions
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pneumonia, Pneumocystis
×
Other hematologic neoplasm
×
Clear all
NCT02944045
2020-10-06
PIC
Assistance Publique - Hôpitaux de Paris
Phase 3
Unknown
222 enrolled